Reliability of self-reported family history of cancer in a large case-control study of lymphoma

被引:105
作者
Chang, ET
Smedby, KE
Hjalgrim, H
Glimelius, B
Adami, HO
机构
[1] No Calif Canc Ctr, Fremont, CA 94538 USA
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[3] State Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark
[4] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[5] Karolinska Inst, Karolinska Univ Hosp, Dept Pathol & Oncol, Stockholm, Sweden
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 01期
关键词
D O I
10.1093/jnci/djj005
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Case-control studies of familial cancer risk traditionally rely on self-reported family history of cancer, which may bias results due to differential recall between case patients and control subjects. To evaluate the reliability of self-reported data, we analyzed questionnaire and registry-based data on familial cancer from a population-based case-control study of malignant lymphoma. Methods: All 1508 lymphoma case patients and 1229 control subjects completed a telephone interview assessing cancer in family members. Participants were linked to the Swedish Multi-Generation Register and Cancer Register to identify confirmed cancer diagnoses in first-degree relatives. The sensitivity and specificity of self-reported familial cancer were calculated among case patients and control subjects and were compared using logistic regression. All statistical tests were two-sided. Results: Lymphoma case patients reported a family history of any cancer with statistically significantly higher sensitivity than control subjects (0.85, 95% confidence interval [CI] = 0.83 to 0.87 and 0.80, 95% CI = 0.77 to 0.82, respectively) but with marginally lower specificity (0.89, 95% CI = 0.87 to 0.91 and 0.92, 95% CI = 0.90 to 0.94, respectively). The sensitivity of self-reporting familial cancers by site ranged from less than 0.20 for rare malignancies to nearly 0.75 for more common types, whereas specificity was generally 0.98 or greater. For most sites, the reliability of self-report was similar in patients and control subjects. However, patients reported familial hematopoietic cancer with statistically significantly higher sensitivity (0.60, 95% CI = 0.57 to 0.62) than control subjects (0.38, 95% CI = 0.35 to 0.40). Odds ratios for the association between familial cancer and risk of non-Hodgkin lymphoma were consistently higher when based on self-reported, compared with registry data-based, family history of any cancer or of hematopoietic cancer. Conclusions: Reliability of self-reported family history of cancer varies between case patients and control subjects. Recall bias may thus produce biased results in case-control studies of familial cancer risk.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 26 条
[1]
HOW ACCURATE IS SELF-REPORTED FAMILY HISTORY OF COLORECTAL-CANCER [J].
AITKEN, J ;
BAIN, C ;
WARD, M ;
SISKIND, V ;
MACLENNAN, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (09) :863-871
[2]
Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database [J].
Altieri, A ;
Bermejo, JL ;
Hemminki, K .
BLOOD, 2005, 106 (02) :668-672
[3]
Family history of hematopoietic malignancy and risk of lymphoma [J].
Chang, ET ;
Smedby, KE ;
Hjalgrim, H ;
Porwit-MacDonald, A ;
Roos, G ;
Glimelius, B ;
Adami, HO .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) :1466-1474
[4]
Chatterjee N, 2004, CANCER EPIDEM BIOMAR, V13, P1415
[5]
Chiu BCH, 2004, CANCER EPIDEM BIOMAR, V13, P525
[6]
INCREASED INCIDENCE OF HEMATOLOGIC MALIGNANCIES IN 1ST-DEGREE RELATIVES OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
CUTTNER, J .
CANCER INVESTIGATION, 1992, 10 (02) :103-109
[7]
Domingo-Domènech E, 2005, HAEMATOLOGICA, V90, P416
[8]
Changes in self-reported family history of breast cancer with change in case-control status [J].
Garbers, V ;
Toniolo, PG ;
Taioli, E .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (06) :517-520
[9]
Familial aggregation of Hodgkin lymphoma and related tumors [J].
Goldin, LR ;
Pfeiffer, RM ;
Gridley, G ;
Gail, MH ;
Li, XJ ;
Mellemkjaer, L ;
Olsen, JH ;
Hemminki, K ;
Linet, MS .
CANCER, 2004, 100 (09) :1902-1908
[10]
HODGKINS-DISEASE IN SIBLINGS [J].
GRUFFERMAN, S ;
COLE, P ;
SMITH, PG ;
LUKES, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (05) :248-250